Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability
Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability
Not yet recruiting · NCT06134401 · Registry updated 2024-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability | Brain Damage, Chronic, brain disorder, central nervous system disorder, cerebral palsy, nervous system disorder, neurodevelopmental disorder, neuromuscular disease, psychiatric disorder | Not yet recruiting | Not applicable | 2024-10-15 | NCT06134401 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Imperial College London | 220 |
| Nottingham University Hospitals NHS Trust | 53 |
| Pari Pharma GmbH | 1 |
| Royal Brompton & Harefield NHS Foundation Trust | 38 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nottingham University Hospitals | Nottingham | United Kingdom | 2 |
| Royal Brompton Hospital | London | United Kingdom | 22 |